viral inactivation Market expected to grow at a 12.3% CAGR
The Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics. The major drivers for the market are rapid growth in pharmaceutical and biotechnology...
Key Players in the Viral Inactivation Market by Product Focus on Partnerships, Agreements, & Collaborations, Mergers & Acquisitions, New Product launches, and Expansions
The Global Viral Inactivation Market by Product expected to grow at a CAGR of 12.3% to reach $ 573.0 Million.
Viral inactivation is an important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing...